Articles published by The Greater Cannabis Company, Inc.
GCANRx Announces Submission of Phase 2 Clinical Trial Application to Treat Autism Related Spectrum Disorders
October 07, 2022
From
The Greater Cannabis Company, Inc.
Via
GlobeNewswire
Tickers
GCAN
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.